Norges Bank’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $85.3M | Buy |
+1,815,111
| New | +$85.3M | 0.01% | 763 |
|
|
2025
Q1 | – | Sell |
-186,503
| Closed | -$6.74M | – | 1478 |
|
|
2024
Q4 | $6.74M | Buy |
+186,503
| New | +$6.74M | ﹤0.01% | 1431 |
|
|
2024
Q3 | – | Sell |
-280,343
| Closed | -$10.6M | – | 1547 |
|
|
2024
Q2 | $10.6M | Sell |
280,343
-77,093
| -22% | -$2.9M | ﹤0.01% | 1383 |
|
|
2024
Q1 | $17.6M | Buy |
357,436
+19,603
| +6% | +$965K | ﹤0.01% | 1305 |
|
|
2023
Q4 | $12.3M | Buy |
337,833
+70,000
| +26% | +$2.56M | ﹤0.01% | 1419 |
|
|
2023
Q3 | $6.19M | Hold |
267,833
| – | – | ﹤0.01% | 1632 |
|
|
2023
Q2 | $7.02M | Hold |
267,833
| – | – | ﹤0.01% | 1630 |
|
|
2023
Q1 | $6.89M | Sell |
267,833
-89,861
| -25% | -$2.31M | ﹤0.01% | 1681 |
|
|
2022
Q4 | $9.3M | Hold |
357,694
| – | – | ﹤0.01% | 1595 |
|
|
2022
Q3 | $10.2M | Sell |
357,694
-154,199
| -30% | -$4.4M | ﹤0.01% | 1533 |
|
|
2022
Q2 | $12.6M | Sell |
511,893
-436,472
| -46% | -$10.7M | ﹤0.01% | 1451 |
|
|
2022
Q1 | $53.5M | Buy |
948,365
+374,584
| +65% | +$21.1M | 0.01% | 844 |
|
|
2021
Q4 | $35.6M | Buy |
573,781
+77,438
| +16% | +$4.8M | 0.01% | 1126 |
|
|
2021
Q3 | $31.5M | Sell |
496,343
-32,623
| -6% | -$2.07M | 0.01% | 1177 |
|
|
2021
Q2 | $43.6M | Buy |
528,966
+92,631
| +21% | +$7.63M | 0.01% | 1051 |
|
|
2021
Q1 | $32.1M | Sell |
436,335
-34,657
| -7% | -$2.55M | 0.01% | 1253 |
|
|
2020
Q4 | $34.2M | Buy |
470,992
+221,980
| +89% | +$16.1M | 0.01% | 1229 |
|
|
2020
Q3 | $11.9M | Buy |
249,012
+24,812
| +11% | +$1.18M | ﹤0.01% | 1659 |
|
|
2020
Q2 | $9.42M | Buy |
224,200
+24,200
| +12% | +$1.02M | ﹤0.01% | 1728 |
|
|
2020
Q1 | $5.4M | Hold |
200,000
| – | – | ﹤0.01% | 1810 |
|
|
2019
Q4 | $7.7M | Hold |
200,000
| – | – | ﹤0.01% | 1850 |
|
|
2019
Q3 | $4.34M | Buy |
+200,000
| New | +$4.34M | ﹤0.01% | 1927 |
|